$CURA.TO

Curaleaf Holdings Opens New Dispensary in Florida

Curaleaf Holdings (CURA.TO) has opened a new location in Tampa Bay area, boosting its retail footprint to 77 dispensaries in Florida and 178 nationwide, the cannabis company said Friday.The Curaleaf Riverview store features a broad range of products and brands for medical patients, the company said.A grand opening celebration is scheduled on Sept. 18-19, according to Curaleaf."This acceleration in the Florida market reflects our long-term strategy to strengthen our presence in this fast-growing medical cannabis market," Chairman and Chief Executive Officer Boris Jordan said."As we continue to expand, we are focused on providing access to comprehensive, curated products offerings and patient-centered services that enhance the shopping experience," Jordan added.

Curaleaf Says Aurora Offer Gives Shareholders "Meaningful" Future Upside

Curaleaf (CURA.TO) on Wednesday reiterated its statement that its hostile offer to acquire Aurora Cannabis (ACB.TO) shares for an offer price of $4.00 and capped at $5.00 each offers a "meaningful" future upside.Aurora shareholders would be able to realize immediate value and participate in the growth of a much larger, more diversified cannabis platform, Curaleaf added.It was responding to statements made by Aurora earlier today where it urged shareholders to reject Curaleaf's offer, describing the bid as "hostile" and "inadequate", and one which aimed to capture Aurora's assets at a discount.Curaleaf shares were last seen up C$0.20 to C$13.86, while Aurora Cannabis shares were up C$0.02 to C$5.62.Price: $13.88, Change: $+0.22, Percent Change: +1.61%

Aurora Cannabis Urges Shareholders to Reject Curaleaf's Takeover Bid

Aurora Cannabis (ACB.TO) urged shareholders to reject Curaleaf Holdings (CURA.TO)'s unsolicited takeover bid, saying that the offer undervalues the company, Aurora said Wednesday.Aurora said Curaleaf is seeking to acquire Aurora's assets at a discount, adding that Curaleaf's debt of over C$1 billion would put Aurora shareholders at risk.The board of Aurora recommended that Aurora shareholders take no action on the bid, and told shareholders who have tendered their shares to the bid to withdraw those shares.Aurora said the company's standalone strategy to exit lower-margin businesses, expand cultivation and manufacturing capacity, and develop an international platform offers better value for shareholders."Curaleaf has over a C$1 billion in debt and is asking shareholders to give up ownership of a stronger, debt-free and growing global medical cannabis company in exchange for an offer with intentionally limited upside, that does not reflect Aurora's fundamental value, exposes shareholders to Curaleaf's risks and would leave shareholders with limited voting influence in a combined company," Aurora Executive Chairman and CEO Miguel Martin said.

Curaleaf Holdings to Open New Dispensary in Miami, Florida

Curaleaf Holdings (CURA.TO) will open a new dispensary in Cutler Bay in Miami, Florida, on Sept. 1, the cannabis company said Monday.The new dispensary will bring the company's Florida footprint to 76 stores and its nationwide store count to 177, said the company."Cutler Bay marks our eighth dispensary in Miami-Dade County, expanding our presence into one of South Florida's fastest-growing communities," said Chief Executive Officer Boris Jordan. "South Miami-Dade continues to show real patient demand, and this location puts us closer to the patients driving it."The company's shares were last seen up C$0.13 at C$13.58 on the Toronto Stock Exchange.Price: $13.56, Change: $+0.11, Percent Change: +0.82%

Update: Aurora Cannabis Acquiring UK Company For 2 Million Pounds Cash

(Updates shares and adds detail on Aurora's UK acquisition in the first two paragraphs.)Aurora Cannabis (ACB.TO), which is fending off a hostile takeover bid by Curaleaf (CURA.TO) Wednesday afternoon said it acquired importer and wholesaler Internode Pharma and HAP Pharma, a pharmacy, both in the UK, for 2.1 million pounds cash.The companies operate an import and distribution facility and a virtual pharmacy in England, and provide Aurora with a supply chain from cultivation through to delivery to patients, a statement said.Aurora earlier today urged shareholders to ignore an unsolicited offer by Curaleaf Holdings (CURA.TO) after it launched its bid for Aurora shares at $4.00 each on Tuesday, consisting of 0.3463 subordinate voting share of Curaleaf and $0.75 in cash per Aurora share.Aurora Cannabis shares were last seen up C$0.22, or 4.3%, to C$5.32 on the Toronto Stock Exchange.Price: $5.31, Change: $+0.21, Percent Change: +4.12%

Aurora Cannabis Tells Shareholders to Ignore Curaleaf's Unsolicited Offer

Aurora Cannabis (ACB.TO) Wednesday morning urged shareholders to take no action on the unsolicited offer by Curaleaf Holdings (CURA.TO).Curaleaf launched its unsolicited take-over bid for Aurora shares at $4.00 each on Tuesday, consisting of 0.3463 subordinate voting share of Curaleaf and $0.75 in cash per Aurora share."Contrary to assertions by Curaleaf, our door is always open to those that see value in our company," said Aurora CEO Miguel Martin. He added that Aurora had been in dialogue with Curaleaf since June 22, and "as recently" as August 12, 2026."Their objective is to acquire Aurora's highly strategic EU-GMP facilities and leading medical cannabis platforms at the lowest price possible, thereby depriving Aurora shareholders of any current and future value they generate," Martin said.Aurora Cannabis shares were last seen up C$0.08, to C$5.18, on the Toronto Stock Exchange. Curaleaf shares were up C$0.10, to C$12.90.Price: $5.17, Change: $+0.07, Percent Change: +1.37%

Curaleaf Launches Unsolicited Take-Over Bid to Buy Aurora Cannabis

Curaleaf (CURA.TO)on Tuesday formally launched its unsolicited takeover bid for Aurora Cannabis (ACB.TO, ACB), it said in a statement on Tuesday.The deal would allow Aurora shareholders to receive total implied consideration of $4.00 per Aurora common share, comprised of 0.3463 of a Curaleaf subordinate voting share and $0.75 in cash and based on Curaleaf's closing share price of $9.39 on Aug. 10, which was the day before the company announced its intention to make the offer. The offer is subject to a maximum value per share of $5.00."Aurora Cannabis, in its response to Curaleaf's Aug. 10 press release noted that the proposal added a cap on the value of the consideration of $5.00 per Aurora share, which is a lower price than Aurora shares have traded as recently as Dec.18, 2025. Aurora Cannabis had also said that its board intended to form a special committee of independent directors to consider the proposal.Curaleaf acknowledged the formation of Aurora Cannabis' Special Committee to review the offer."We remain disappointed that Aurora's management and Board have not meaningfully engaged with us on the merits of our proposal. A one-line response to an offer is not meaningful engagement - it is a dismissal - and Aurora shareholders deserve the opportunity to fully evaluate the potential benefits of this transaction," said Curaleaf chief executive Boris Jordan."However, we are hopeful that Aurora's Special Committee will see, as we do, that the financial and strategic rationales for a combination with Curaleaf are compelling, and that this transaction is in the best interest of Aurora shareholders. We remain available for productive conversations with the Special Committee to ensure that the benefits of the combination can be realized by the shareholders of both of our companies as soon as possible," Jordan continued.Curaleaf's offer will remain open for acceptance until 5:00 p.m., Mountain Time, on Dec. 1, unless extended, varied or withdrawn in accordance with its terms, it said.Shares of Curaleaf were last seen down 2.5% at C$12.66 on the Toronto Stock Exchange. Aurora Cannabis shares were up 3% at C$5.15 on the TSX.Price: $12.93, Change: $-0.06, Percent Change: -0.46%

Update: Curaleaf Proposing to Acquire Aurora Cannabis For $4.00 Per Share

(Updates with Aurora Cannabis' response in the fifth, sixth and seventh paragraphs and updates shares in final paragraph.)Curaleaf Holdings (CURA.TO) on Tuesday said it is proposing to acquire Aurora Cannabis (ACB.TO) at $4.00 per share.It is making its intention public after two attempts to engage with the Aurora board had met with silence, Curaleaf said. It sent a formal letter of intent on June 23 outlining Curaleaf's proposal, and a follow-up letter on July 7. No formal offer has been made.The offer, comprised of 0.35 of a Curaleaf share, plus $0.75 cash per Aurora share, implies a 45% premium based on Aurora's 30-day volume weighted average price (VWAP) of $2.75.The Curaleaf statement noted the combined company would have a footprint in 17 countries spanning Europe, North America, and other emerging international markets.Aurora confirmed on Tuesday afternoon that it received Curaleaf's unsolicited takeover proposal. The company also pushed back on Curaleaf's claim that it refused to engage and said its lead independent director remained in contact with Curaleaf's CEO as recently as July 24.The board plans to form a special committee of independent directors to review the proposal and determine what is in the best interests of Aurora and its shareholders, the company added."No decision has been made with respect to the proposal, and there can be no assurance that the proposal will result in any transaction," Aurora said.Aurora shares closed up C$1.00, or 25%, to C$5.03 on the Toronto Stock Exchange, whlle Curaleaf rose C$0.72, or 5.5%, to C$13.80.

Curaleaf Proposing to Acquire Aurora Cannabis For $4.00 Per Share

Curaleaf Holdings (CURA.TO) on Tuesday said it is proposing to acquire Aurora Cannabis (ACB.TO) at $4.00 per share.It is making its intention public after two attempts to engage with the Aurora board had met with silence, Curaleaf said. It sent a formal letter of intent on June 23 outlining Curaleaf's proposal, and a follow-up letter on July 7. No formal offer has been made.The offer, comprised of 0.35 of a Curaleaf share, plus $0.75 cash per Aurora share, implies a 45% premium based on Aurora's 30-day volume weighted average price (VWAP) of $2.75.The Curaleaf statement noted the combined company would have a footprint in 17 countries spanning Europe, North America, and other emerging international markets.Aurora Cannabis has not yet released a statement.Curaleaf shares were last seen up C$0.16, to C$13.24, on the Toronto Stock Exchange, while Aurora Cannabis shares jumped 20.35% to C$4.85.Price: $13.21, Change: $+0.13, Percent Change: +0.99%

S&P/TSX Composite Index up Nearly 107 Points Mid-Morning Tuesday

The S&P/TSX Composite Index, is up near 107 points mid-morning Tuesday with most sectors higher.Utilities and telecommunications are the best performers, gaining 1.1% each, followed by the industrials sector, up 0.8%.Limiting gains is information technology, down 0.8%.The S&P/TSX Battery Metals Index, which includes issues listed both on the TSX and TSX Venture Exchange, was 4.1%, on last look.In stocks, Pet Valu (PET.TO), jumped nearly 10.4% to C$20.75, after it reported a second-quarter adjusted earnings beat earlier Tuesday.Cannabis company Aurora Cannabis (ACB.TO) surged 20.4% to C$4.83 after Curaleaf (CURA.TO) announced its plans to acquire the company for $4.00 per share.

Curaleaf Holdings Swings to Second-quarter Profit, Higher Revenue

Curaleaf Holdings (CURA.TO) after trade Wednesday reported its second-quarter net income per share from continuing operations at $0.05, swinging from a loss of $0.24 a year ago.Analysts polled by FactSet expected a loss per share of $0.17.Net revenue for the quarter ended June 30 rose to $340.1 million from $310.6 million a year earlier.Analysts polled by FactSet expected $332.3 million.

Earnings Flash (CURA.TO) Curaleaf Holdings, Inc. Reports Q2 Revenue $340.1M, vs. FactSet Est of $332.3M

Curaleaf Holdings to Open New Florida Dispensary in Boynton Beach

Curaleaf Holdings (CURA.TO) will open its new Florida dispensary in Boynton Beach on July 31, it said Wednesday.The new dispensary will bring the cannabis-retailer's footprint to 75 stores in Florida, and to 167 nationwide."Boynton Beach marks our sixth opening in Florida this year, with the state now representing nearly half of our retail footprint," said Chief Executive Officer Boris Jordan.The company's shares were last seen down C$0.54, or 4.4%, to C$11.58 on the Toronto Stock Exchange.Price: $11.56, Change: $-0.56, Percent Change: -4.62%

Curaleaf Holdings Opens New Dispensary in Florida

Curaleaf Holdings (CURA.TO) on Wednesday said it will open another Florida cannabis dispensary on Friday, expanding its footprint in the state to 74 locations and bringing its total nationwide store count to 166."As we continue expanding our footprint across the state, we remain focused on serving the growing medical cannabis community with trusted products designed with Florida patients in mind," said chief executive Boris Jordan.Curaleaf shares were last seen down C$0.16, or 1.2%, to C$13.71, on the Toronto Stock Exchange.Price: $13.71, Change: $-0.16, Percent Change: -1.15%

Cannara Biotech Strikes Long-Term Supply Agreement With Curaleaf

Cannara Biotech (LOVE.TO) on Tuesday said it sealed a deal with Curaleaf (CURA.TO) to supply bulk cannabis flower for export to international markets.The agreement, Cannara's first long-term international supply commitment, is valued at up to C$21 million if fully-realized.The company has opened two additional cultivation zones at its Valleyfield facility in Quebec, to bring total zones in production to 14 out of 24 grow zones of 25,000 square feet each.To meet the expected commercial demand, Cannara will also activate four additional cultivation zones by the end of fiscal 2027. This is projected to hike annual production capacity to 75,000 kilograms, enabling Cannara to reach its targeted production capacity one year ahead of its original fiscal 2028 timeline.Cannara shares were last seen up C$0.10, or 5.6%, to C$1.89 on the Toronto Stock Exchange.Price: $1.89, Change: $+0.10, Percent Change: +5.59%

Curaleaf Secure Registration For Two Standardized Cannabis Preparations in Spain

Curaleaf Holdings (CURA.TO) said the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved the registration of two standardized cannabis preparations developed by Curaleaf's Spanish subsidiary.The registrations clear the regulatory pathway for the supply of preparations to hospital pharmacies.Curaleaf says it is the first company to register standardized cannabis preparations in Spain under the country's new regulatory framework.

Curaleaf's Exchange-Traded Options to Trade on Montreal Exchange

Curaleaf Holdings (CURA.TO) said Friday exchange-traded options on its shares are expected to start trading on the Montreal Exchange (MX) on July 13, under the symbol "CURA".The company believes the listing will increase liquidity and attract options traders, and institutional investors whose strategies include derivatives."The listing of exchange-traded options on the Montreal Exchange reflects Curaleaf's market capitalization, trading depth and growing institutional relevance," said Chief Executive Boris Jordan.Curaleaf shares were last seen up C$0.20, to C$13.37 on the Toronto Stock Exchange.Price: $13.39, Change: $+0.22, Percent Change: +1.67%

Curaleaf Confirms Previously Announced 1-for-3 Reverse Stock Split of Its Subordinate Voting Shares Will Become Effective on June 5, 2026

Curaleaf Launches Stock Split Ahead of Planned U.S. Stock Exchange Uplisting

Cannabis company Curaleaf (CURA.TO) has launched a 1-for-3 reverse stock split of its shares ahead of its planned U.S. stock exchange uplisting, the company said Tuesday.The reverse stock split will become effective about June 5 and ensures that the company meets the share price level criteria established by U.S. exchanges.The reverse stock split also allows the company's shares to trade above limits set by certain retail brokerage firms, and to broaden institutional investor participation, Curaleaf said.Following the stock split, Curaleaf's issued and outstanding subordinate voting shares will be reduced to 232,909,336 from 698,728,008 shares."Rescheduling of medical cannabis has created a potential pathway toward uplisting to a major U.S. exchange, and we're now more prepared than ever," CEO Boris Jordan said.

Curaleaf Announcing 1-for-3 Reverse Stock Split in Preparation for U.S. Stock Exchange Uplisting

Curaleaf (CURA.TO), an international provider of consumer cannabis products, announced Tuesday that a 1-for-3 reverse stock split of its shares will become effective on or about June 5, 2026, as the company prepares for U.S. Stock Exchange uplisting, in response to cannabis rescheduling in that country.Curaleaf's board has approved a proposal to effect a reverse stock split of the company's subordinate voting shares at a ratio of one post-consolidation share for each three pre-consolidation shares, a statement said. This initiative is being done in consultation with major U.S. stock exchanges, and is expected to enable the company to uplist as soon as the opportunity is available, it added.Shares in CURA rose $0.08 or 1.7% at $4.70 in Canada yesterday.